---
id: antimicrobials_mupirocin-mrsa-decolonization_043
category: antimicrobials
tags: [antimicrobials, mupirocin, MRSA, decolonization, chlorhexidine, resistance]
deck: Infectious Diseases
created: 2025-11-10
modified: 2025-11-10
---

## Mupirocin for MRSA Decolonization

**Q:** What is the standard MRSA decolonization protocol using mupirocin, and what are the concerns regarding resistance?

**A:**

**Mechanism:**
- Inhibits **isoleucyl-tRNA synthetase** → disrupts bacterial protein synthesis
- Bactericidal against MRSA and MSSA

**Standard Decolonization Protocol:**

| **Component** | **Regimen** |
|---------------|-------------|
| **Intranasal mupirocin 2%** | Apply BID to both nares x **5 days** |
| **Chlorhexidine 4% body wash** | Daily shower/bath x **5 days** (optional but recommended) |
| **Oral chlorhexidine rinse** | 0.12% BID x 5 days (if oral carriage) |

**Indications for Decolonization:**
1. **Recurrent MRSA SSTI** (skin/soft tissue infections)
2. **Pre-operative prophylaxis:**
   - Cardiac surgery (CABG, valve)
   - Orthopedic surgery (arthroplasty)
   - Screen MRSA carriers → decolonize before surgery
3. **ICU patients** (some protocols)
4. **Outbreak control**

**Efficacy:**
- **1 week post-treatment:** 90% decolonization rate
- **1 month:** Decreased colonization persists
- **9 months:** Serial decolonization maintains lower colonization with chlorhexidine + mupirocin + oral chlorhexidine

**Resistance Concerns:**

**Universal vs Targeted Decolonization:**
- **Universal:** Treat all patients without screening
  - ↑↑ Mupirocin resistance: 21% in 5 years (modeling study)
- **Targeted (screen-and-treat):** Screen → treat only carriers
  - ↑ Mupirocin resistance: 9% in 5 years
  - **Preferred strategy** to preserve susceptibility

**High-Level Mupirocin Resistance:**
- Emerging problem
- Cross-resistance possible

**Mnemonic: "Mupirocin = Must Use Prudently In Colonized Individuals to Avoid Resistance"**

**2024 Update:**
- **Targeted screening and decolonization** preferred over universal
- Mupirocin without chlorhexidine soap may be sufficient for THA (2024 study - 15 years data)
- Combined mupirocin-chlorhexidine remains effective when used judiciously

**Clinical Pearl:**
- **Don't overuse:** Screen first, decolonize only if MRSA-positive
- Repeat decolonization if recurrent SSTI despite initial decolonization
- Check local resistance patterns (mupirocin susceptibility)

**Alternative Agents (if mupirocin resistance):**
- Retapamulin
- Povidone-iodine nasal antiseptic
- Oral agents (rifampin + doxycycline or TMP-SMX) - less effective

**Media:** None

**Sources:** [PMC 2023 - Chlorhexidine/mupirocin after hospital discharge], [PMC 2022 - RCT chlorhexidine/mupirocin/rifampin/doxycycline], [Antimicrobial Resistance & Infection Control 2015], [JAMA Network Open 2021 - Decolonization in ICU], [PubMed 2024 - Mupirocin THA study], [NCBI 2024 - Systematic review]
